Reported 28,421 shares, up 2,736 (10.7%) from the prior quarter.
Reported value -43.7%; share count 10.7% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 854000 |
| 2021-12-31 | 1236000 |
| 2022-03-31 | 126000 |
| 2022-06-30 | 71000 |
| 2022-09-30 | 54000 |
| 2022-12-31 | 68813 |
| 2023-03-31 | 207163 |
| 2023-06-30 | 293139 |
| 2023-09-30 | 182027 |
| 2023-12-31 | 262049 |
| 2024-03-31 | 175707 |
| 2024-06-30 | 73180 |
| 2024-09-30 | 56150 |
| 2024-12-31 | 63562 |
| 2025-03-31 | 55856 |
| 2025-06-30 | 199542 |
| 2025-09-30 | 143195 |
| 2025-12-31 | 14288 |
| 2026-03-31 | 20320 |
| 2026-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Reduced | 0 | -88,350 (-100.0%) | 0 | $0 | 2026-08-13 | |
| Q1 2026 | Added | 88,350 | +41,502 (88.6%) | < 0.01% | $20,320 | 2026-05-05 | |
| Q4 2025 | Reduced | 46,848 | -152,310 (-76.5%) | < 0.01% | $14,288 | 2026-01-29 | |
| Q3 2025 | Reduced | 199,158 | -93,425 (-31.9%) | < 0.01% | $143,195 | 2025-11-13 | |
| Q2 2025 | Added | 292,583 | +231,270 (377.2%) | < 0.01% | $199,542 | 2025-08-14 | |
| Q1 2025 | Added | 61,313 | +2,999 (5.1%) | < 0.01% | $55,856 | 2025-05-13 | |
| Q4 2024 | Reduced | 58,314 | -15,861 (-21.4%) | < 0.01% | $63,562 | 2025-02-14 | |
| Q3 2024 | Added | 74,175 | +15,159 (25.7%) | < 0.01% | $56,150 | 2024-11-14 | |
| Q2 2024 | Reduced | 59,016 | -33,951 (-36.5%) | < 0.01% | $73,180 | 2024-08-14 | |
| Q1 2024 | Reduced | 92,967 | -6,294 (-6.3%) | < 0.01% | $175,707 | 2024-05-13 | |
| Q4 2023 | Added | 99,261 | +20,119 (25.4%) | < 0.01% | $262,049 | 2024-02-09 | |
| Q3 2023 | Reduced | 79,142 | -1,170 (-1.5%) | < 0.01% | $182,027 | 2023-11-09 | |
| Q2 2023 | Added | 80,312 | +22,283 (38.4%) | < 0.01% | $293,139 | 2023-08-11 | |
| Q1 2023 | Added | 58,029 | +33,884 (140.3%) | < 0.01% | $207,163 | 2023-05-12 | |
| Q4 2022 | Unchanged | 24,145 | 0 (0.0%) | < 0.01% | $68,813 | 2023-02-08 | |
| Q3 2022 | Reduced | 24,145 | -4,276 (-15.0%) | < 0.01% | $54,000 | 2022-11-10 | |
| Q2 2022 | Added | 28,421 | +2,736 (10.7%) | < 0.01% | $71,000 | 2022-08-10 | |
| Q1 2022 | Reduced | 25,685 | -83,614 (-76.5%) | < 0.01% | $126,000 | 2022-05-16 | |
| Q4 2021 | Added | 109,299 | +50,709 (86.5%) | < 0.01% | $1,236,000 | 2022-02-14 | |
| Q3 2021 | Added | 58,590 | +31,573 (116.9%) | < 0.01% | $854,000 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
107 managers reported CUE BIOPHARMA INC for Q2 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Prosight Management LP | Added | 1,655,477 | +145,195 | 3.25% | $4,122,000 | 11 qtrs |
| VANGUARD GROUP INC | Reduced | 1,522,319 | -131,418 | < 0.01% | $3,791,000 | 18 qtrs |
| Slate Path Capital LP | Unchanged | 1,483,619 | 0 | 0.23% | $3,694,000 | 12 qtrs |
| BlackRock Inc | Reduced | 831,925 | -1,549,342 | < 0.01% | $2,072,000 | 18 qtrs |
| SANDERS MORRIS HARRIS LLC | Reduced | 736,212 | -136,809 | 0.39% | $1,803,000 | 8 qtrs |
| DIMENSIONAL FUND ADVISORS LP | Reduced | 668,634 | -73,269 | < 0.01% | $1,666,000 | 5 qtrs |
| MILLENNIUM MANAGEMENT LLC | Added | 602,205 | +481,735 | < 0.01% | $1,499,000 | 9 qtrs |
| CARLSON CAPITAL L P | Added | 580,000 | +175,000 | 0.1% | $1,444,000 | 7 qtrs |
| RENAISSANCE TECHNOLOGIES LLC | Added | 579,700 | +60,400 | < 0.01% | $1,443,000 | 3 qtrs |
| Bleichroeder LP | Added | 555,000 | +3,000 | 0.29% | $1,382,000 | 11 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2022
- Filed
- August 10, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 0
- Shared
- 4,276
- None
- 24,145
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.